C

Crinetics Pharmaceuticals
D

CRNX

29.800
USD
0.35
(1.19%)
مغلق
حجم التداول
26,026
الربح لكل سهم
-5
العائد الربحي
-
P/E
-8
حجم السوق
2,791,667,874
أصول ذات صلة
A
ALLO
-0.00500
(-0.42%)
1.18500 USD
A
ASND
1.325
(0.77%)
174.320 USD
A
AUPH
0.09000
(1.20%)
7.57000 USD
INCY
INCY
0.300
(0.44%)
68.470 USD
P
PRQR
0.05000
(2.35%)
2.18000 USD
المزيد
الأخبار المقالات

العنوان: Crinetics Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.